TABLE 1.
Patient no. | Plasma artesunate concn (μg · liter−1) at sampling time (h)
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0a | 2 | 12a | 14 | 24b | 26c | 96b | 98 | 100 | 102 | 104 | 106 | 108 | 112 | 120 | |
1 | 0 | 2 | 7 | 7 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 |
2 | 0 | 20 | 18 | 18 | 24 | 12 | 4 | 4 | 4 | 5 | 6 | 3 | 12 | 26 | 10 |
3 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | 0 | 9 | 7 | 10 | 4 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 0 | —d | 16 | 20 | 12 | 50 | 12 | — | 12 | 10 | — | 0 | 0 | 0 | 0 |
6 | 0 | 10 | 7 | 16 | 6 | 9 | — | 4 | — | — | — | 4 | 4 | 4 | 0 |
Mean | 0 | 8 | 9 | 12 | 8 | 14 | 4 | 2 | 4 | 4 | 3 | 1 | 3 | 5 | 2 |
SD | 0 | 8 | 7 | 8 | 9 | 18 | 5 | 2 | 5 | 4 | 3 | 2 | 5 | 11 | 4 |
A 150-mg dose of artesunate was administered at this time.
A 100-mg dose of artesunate was administered at this time.
For the two subsequent dosing periods (48 and 72 h), 100-mg doses of artesunate were administered but concentrations in plasma were not determined.
—, missing value.